Genus Capital Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$15.6M Buy
44,427
+43,340
+3,987% +$15.5M 1.79% 11
2025
Q4
$356K Hold
1,087
0.04% 164
2025
Q3
$307K Sell
1,087
-9,508
-90% -$2.76M 0.04% 175
2025
Q2
$2.96M Sell
10,595
-9,690
-48% -$2.75M 0.38% 80
2025
Q1
$6.32M Buy
+20,285
New +$5.99M 0.92% 39
2024
Q2
Sell
-23,195
Closed -$6.81M 204
2024
Q1
$6.59M Buy
+23,195
New +$6.79M 0.86% 34
2023
Q3
Sell
-2,879
Closed -$639K 183
2023
Q2
$639K Buy
+2,879
New +$668K 0.09% 151

Other funds holding AMGN

Genus Capital Management's AMGN Position: Q1 2026 in Review

Genus Capital Management increased its Amgen (AMGN) stake by 3,987% in Q1 2026, buying an estimated $15.5M and bringing the position to 44,427 shares worth $15.6M. The position accounts for 1.79% of the portfolio, ranked #11.

Genus Capital Management first reported a position in AMGN in Q2 2023 and has held it in 7 quarters since. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Genus Capital Management held 44,427 shares of Amgen worth $15.6M as of Q1 2026.
  • Genus Capital Management bought 43,340 Amgen shares in Q1 2026, an estimated $15.5M.
  • Amgen made up 1.79% of Genus Capital Management's portfolio in Q1 2026, its #11 holding.
  • Genus Capital Management first reported a position in Amgen in Q2 2023 and has held it in 7 quarters since.
  • 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Genus Capital Management's 13F filing for Q1 2026, filed 4 May 2026.